Biotech · Private company

Allucent (US) LLC

Track this companyFree. Adds Allucent (US) LLC to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)PHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07881952 · fetched Nov 12, 2026
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026